Ciphergen has named Steve Lundy senior vice president of sales and marketing, the company said this week.
Lundy comes to Ciphergen from GeneOhm, where he was vice president of sales and marketing. GeneOhm was acquired last year by Becton Dickinson. He had worked earlier as vice president of marketing at Esoterix and was marketing director of molecular diagnostics and critical care testing at Bayer Diagnostics.
Pathwork Diagnostics has appointed W. David Henner chief medical officer, and it has named David Craford vice president of commercial operations.
Henner formerly was vice president of oncology at Novacea, and Craford previously served as vice president of business development at Affymetrix.